Amphista Therapeutics Reaches Discovery Milestone in Merck Collaboration for Next-Gen Protein Degraders

Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of next-generation, Targeted Protein Degradation (...

July 17, 2025 | Thursday | News
BriaCell Adds Mayo Clinic as Site for Pivotal Phase 3 Metastatic Breast Cancer Trial

BriaCell Therapeutics Corp.  a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, is pleased to announc...

July 16, 2025 | Wednesday | News
Addgene and Promega Launch Plasmid Collection to Accelerate Drug Discovery Research

Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility,  announced a strategic ...

July 16, 2025 | Wednesday | News
Golden Age Health and Innostellar Sign Exclusive 10-Year Deal to Deliver Sight-Saving Gene Therapy LX-101 Across China

Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”)  announced an exclusive ten-ye...

July 14, 2025 | Monday | News
Secarna and Vect-Horus Join Forces to Unlock RNA Therapeutics for CNS Disorders

  The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable system...

July 11, 2025 | Friday | News
Amarna Therapeutics and NorthX Biologics Advance Gene Therapy Manufacturing for Type 1 Diabetes

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company pioneering transformative gene therapies...

July 09, 2025 | Wednesday | News
Certara Expands Partnership with Merck to Advance Metadata and Data Standards Management

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of...

July 09, 2025 | Wednesday | News
Oxford BioTherapeutics Achieves Milestone as Boehringer Ingelheim Selects Third Cancer Drug Candidate for IND-Enabling Studies

Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford BioTherapeutics’ proprietary OGA...

July 07, 2025 | Monday | News
MaaT Pharma and Clinigen Sign Exclusive European Licensing Deal for Xervyteg® in Acute Graft-Versus-Host Disease

MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg® (MaaT013),...

July 03, 2025 | Thursday | News
Modella AI and AstraZeneca Forge Multi-Year Alliance to Power Oncology R&D with Multimodal AI

-Modella AI, a leader in artificial intelligence for life sciences,  announced a multi-year agreement with AstraZeneca. Under the agreement, Modella...

July 03, 2025 | Thursday | News
Alvotech and Advanz Pharma Forge Agreement to Commercialise Biosimilar Candidate to Cimzia® Across Europe

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

July 02, 2025 | Wednesday | News
HUTCHMED and AstraZeneca Secure China Approval for ORPATHYS®–TAGRISSO® Combination in EGFR-Mutant NSCLC with MET Amplification

HUTCHMED (China) Limited  announces that the New Drug Application (“NDA”) for the combination of ORPATHYS® (savolitinib) and TAGRISS...

July 01, 2025 | Tuesday | News
Mabion and NovalGen Forge Strategic Partnership to Advance First-in-Class T-Cell Engager NVG-222 Into Clinical Trials

In a significant move to accelerate the global fight against blood cancers and hard-totreat solid tumours, renowned end- to-end biologics CDMO Mabion hav...

June 30, 2025 | Monday | News
Invetech and AiCella Forge Strategic Alliance to Accelerate AI-Driven Cell Therapy Manufacturing

Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today an...

June 27, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close